Table 5

Cost-effectiveness of mass screening using 12-miR assay in conjunction with endoscopy

StrategyCurrent practice: no screeningMass screening with 3-yearly follow-ups
Cost(US$)173533
Δ Costs(US$)+360
Efficiency(QALY)10.503210.5113
Δ Efficiency(QALY)+0.008
ICER(US$/QALY)44 531
  • ICER, Incremental cost-effectiveness ratio; miR, microRNA; QALY, Quality-adjusted life years.